These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18615394)

  • 1. Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment.
    Mizia-Stec K; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Mucha Z; Holecki M; Gasiora Z
    Endokrynol Pol; 2008; 59(3):207-11. PubMed ID: 18615394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of weight reduction on plasma concentrations of ghrelin and insulin-like growth factor 1 in obese women.
    Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
    Endokrynol Pol; 2008; 59(4):301-4. PubMed ID: 18777499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of weight reduction on serum ghrelin and TNFalpha concentrations in obese women.
    Zahorska-Markiewicz B; Mizia-Stec K; Olszanecka-Glinianowicz M; Janowska J
    Eur J Intern Med; 2004 Jun; 15(3):172-175. PubMed ID: 15245720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of ghrelin and leptin in response to hypocaloric diet in obese patients.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
    Nutrition; 2008 Feb; 24(2):162-6. PubMed ID: 18165128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes.
    Kelishadi R; Hashemipour M; Mohammadifard N; Alikhassy H; Adeli K
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):721-9. PubMed ID: 18284632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a moderately hypoenergetic Mediterranean diet and exercise program on body cell mass and cardiovascular risk factors in obese women.
    Andreoli A; Lauro S; Di Daniele N; Sorge R; Celi M; Volpe SL
    Eur J Clin Nutr; 2008 Jul; 62(7):892-7. PubMed ID: 17522604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of plasma ghrelin, obestatin, and ghrelin/obestatin ratio on blood pressure circadian rhythms in patients with obstructive sleep apnea syndrome.
    Liu W; Yue H; Zhang J; Pu J; Yu Q
    Chin Med J (Engl); 2014; 127(5):850-5. PubMed ID: 24571875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of weight loss on serum concentrations of nitric oxide, TNF-alpha and soluble TNF-alpha receptors.
    Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Janowska J
    Endokrynol Pol; 2006; 57(5):487-93. PubMed ID: 17133313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of weight loss on serum concentrations of FAS and tumour necrosis factor alpha in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P
    Endokrynol Pol; 2008; 59(1):18-22. PubMed ID: 18335396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
    Cummings DE; Weigle DS; Frayo RS; Breen PA; Ma MK; Dellinger EP; Purnell JQ
    N Engl J Med; 2002 May; 346(21):1623-30. PubMed ID: 12023994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m².
    Lang HF; Chou CY; Sheu WH; Lin JY
    Nutr Res; 2011 May; 31(5):378-86. PubMed ID: 21636016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin levels before and after reduction of overweight due to a low-fat high-carbohydrate diet in obese children and adolescents.
    Reinehr T; Roth CL; Alexy U; Kersting M; Kiess W; Andler W
    Int J Obes (Lond); 2005 Apr; 29(4):362-8. PubMed ID: 15768041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight.
    Reinehr T; de Sousa G; Roth CL
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):304-10. PubMed ID: 17854392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in ghrelin concentrations one year after resective and non-resective gastric bypass: associations with weight loss and energy and macronutrient intakes.
    Carrasco F; Rojas P; Csendes A; Codoceo J; Inostroza J; Basfi-fer K; Papapietro K; Watkins G; Rojas J; Ruz M
    Nutrition; 2012 Jul; 28(7-8):757-61. PubMed ID: 22305536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.
    Esposito K; Pontillo A; Di Palo C; Giugliano G; Masella M; Marfella R; Giugliano D
    JAMA; 2003 Apr; 289(14):1799-804. PubMed ID: 12684358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lifestyle modification on adipocytokine levels in obese patients.
    De Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2008; 12(1):33-9. PubMed ID: 18401970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating ghrelin levels in obese women: a possible association with hypertension.
    Oner-Iyidoğan Y; Koçak H; Gürdöl F; Oner P; Issever H; Esin D
    Scand J Clin Lab Invest; 2007; 67(5):568-76. PubMed ID: 17763194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.